News

Home > News > Enantia has received permission from AEMPS …

EnantiahasreceivedpermissionfromAEMPS

Enantia has received permission from AEMPS to carry out studies with narcotic and psychotropic substances

May 15th, 2018

Enantia has received permission from the Spanish Agency of Medicines and Medical Devices (AEMPS) to carry out a study with a narcotic substance from the Lists I to IV, included in the Single Convention on Narcotic Drugs, 1961.
 
Furthermore, Enantia has also obtained permission from the AEMPs to work with a psychotropic substance controlled under the Convention on Psychotropic Substances, 1971.
 
In order to comply with the corresponding legal requirements we have developed new standard operating procedures and adapted our facilities. This opens the door for new authorisations to apply our expertise in Medicinal Chemistry and Process Chemistry, as well as in Solid Form Development in new projects with narcotic and psychotropic substances.
 
If you are looking for a reliable chemistry CRO who is able to work with narcotic and psychotropic substances do not hesitate to contact us.